Open Access
| Issue |
Med Sci (Paris)
Volume 38, Number 8-9, Août-Septembre 2022
|
|
|---|---|---|
| Page(s) | 646 - 647 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2022095 | |
| Published online | 12 September 2022 | |
- Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med 2015 ; 12 : 106–116. [PubMed] [Google Scholar]
- M-Rabet M, Bertucci F, Birnbaum D, Lopez M. Nectine-4 : un biomarqueur pronostique et une cible thérapeutique potentielle dans le cancer du sein triple-négatif. Med Sci (Paris) 2017 ; 33 : 936–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Ansari L, Shiehzadeh F, Taherzadeh Z, et al. The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials. Cancer Gene Ther 2017 ; 24 : 189–193. [CrossRef] [PubMed] [Google Scholar]
- Ahern TP, Lash TL, Damkier P, et al. Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol 2014 ; 15 : e461–e468. [CrossRef] [PubMed] [Google Scholar]
- Yao H, He G, Yan S, et al. Triple-negative breast cancer: is there a treatment on the horizon?. Oncotarget 2017 ; 8 : 1913–1924. [CrossRef] [PubMed] [Google Scholar]
- Wu QJ, Tu C, Li YY, et al. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 2015 ; 6 : 42988–43004. [CrossRef] [PubMed] [Google Scholar]
- Abdoul-Azize S, Buquet C, Li H, et al. Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin. Oncogene 2018 ; 37 : 4979–4993. [CrossRef] [PubMed] [Google Scholar]
- Babula P, Krizanova O. Involvement of calcium signaling in different types of cell death in cancer. Neoplasma 2022 ; 69 : 264–73. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.